The potential of mesenchymal stem cells to induce immune tolerance to allogeneic transplants

Transpl Immunol. 2023 Oct 20:101939. doi: 10.1016/j.trim.2023.101939. Online ahead of print.ABSTRACTOrgan allograft transplantation is an effective treatment plan for patients with organ failure. Although the application of continuous immunosuppressants makes successful allograft survival possible, the patients' long-term survival rate and quality of life are not ideal. Therefore, it is necessary to find a new strategy to alleviate transplant rejection by developing therapies for permanent allograft acceptance. One promising approach is the application of tolerogenic mesenchymal stem cells (MSCs). Extensive research on MSCs has revealed that MSCs have potent differentiation potential and immunomodulatory properties. This review describes the molecular markers and functional properties of MSCs as well as the immunomodulatory mechanisms of MSCs in transplantation, focuses on the research progress in clinical trials of MSCs, and expounds on the future development prospects and possible limitations.PMID:37866668 | DOI:10.1016/j.trim.2023.101939
Source: Transplant Immunology - Category: Transplant Surgery Authors: Source Type: research